ArticleBMJ public health2025
Estimation of unconfirmed COVID-19 cases from a cross-sectional survey of >10 000 households and a symptom-based machine learning model in Gilgit-Baltistan, Pakistan.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Robust estimates of COVID-19 prevalence in settings with limited capacity for SARS-CoV-2 molecular and serologic testing are scarce. We aimed to describe the epidemiology of confirmed and probable COVID-19 in Gilgit-Baltistan, and to develop a symptom-based predictive model to identify infected but undiagnosed individuals with COVID-19. Methods: We conducted a cross-sectional survey in 10 257 randomly selected households in Gilgit-Baltistan from June to August 2021. Data regarding SARS-CoV-2 testing, healthcare worker (HCW) diagnoses, symptoms and outcomes since March 2020 were self-reported by households. 'Confirmed/probable' infection was defined as a positive test, HCW COVID-19 diagnosis or HCW pneumonia diagnosis with COVID-19-positive contact. Robust Poisson regression was conducted to assess differences in symptoms, outcomes and SARS-CoV-2 testing rates. We developed a symptom-based machine learning model to differentiate confirmed/probable infections from those with negative tests. We applied this model to untested respondents to estimate the total prevalence of SARS-CoV-2 infection. Results: Data were collected for 77 924 people. Overall, 314 (0.5%) had confirmed/probable infections, 3263 (4.4%) had negative tests and 74 347 (95.1%) were untested. Children were tested less often than adults (adjusted prevalence ratio (aPR) 0.08, 95% CI 0.06 to 0.12 for ages 1-4 years vs 30-39 years), while males were tested more often than females (aPR 1.51, 95% CI 1.40 to 1.63). In the predictive model, area under the receiver operating characteristic curve was 0.92 (95% CI 0.90 to 0.93). We estimate there were 8-17 total SARS-CoV-2 infections for each positive test (8-17:1). The ratio of estimated to confirmed cases was higher for ages 1-4 years (211-480:1), 5-9 years (80-185:1) and for females (13-25:1). Conclusions: From March 2020 to August 2021, the majority of SARS-CoV-2 infections in Gilgit-Baltistan went unconfirmed, particularly among women and children. Predictive models which incorporate self-reported symptoms may improve understanding of the burden of disease in settings lacking diagnostic capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.